Loading...
P6
Tamoxifen, a selective estrogen receptor modulator, remains a standard of endocrine therapy for estrogen receptor alpha (ERα) positive breast cancer (Goldhirsch et al., 2013). Despite well-known advantages of tamoxifen treatment, approximately one third of patients experience a relapse or disease pr...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Elsevier
2015-11-01
|
Serier: | EJC Supplements |
Online adgang: | http://www.sciencedirect.com/science/article/pii/S1359634915000051 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|